Shandong Suncadia Medicine Co., Ltd.

This study is testing whether an investigational drug called HRS-7535 can help adults who have both heart failure and obesity. About 225 participants will receive either the drug or a placebo for 36 weeks to see if it helps with weight control and heart failure symptoms. The main…

This large study is testing whether a new drug called HRS-8080 works better than standard hormone therapy at preventing breast cancer from returning. It involves 4,800 women with high-risk early breast cancer who have already completed 2-5 years of initial hormone treatment. The …

This study is testing a new drug called HRS-7058, given in combination with other anti-cancer drugs, in adults with solid tumors. The main goals are to find a safe and effective dose, check for side effects, and see if the treatment can shrink tumors. It will enroll about 100 par…

This study is testing the safety and effectiveness of a new drug, HRS-8080, when given together with an existing drug, dalpiciclib, for people with a specific type of advanced breast cancer that has spread and cannot be surgically removed. The goal is to see if this combination c…

This large Phase 3 study is testing whether an investigational drug called HRS-1780 can slow the decline of kidney function in adults with chronic kidney disease. Nearly 2,000 participants will receive either HRS-1780 tablets or a placebo in addition to their standard care. The m…

This study is testing whether a new drug called HRS-8080, when combined with dalpiciclib, works better than the current standard treatment (fulvestrant with dalpiciclib) for advanced breast cancer that has become resistant to previous hormone therapies. It will involve about 912 …

This study is testing an experimental pill called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goals are to see if the pill is safe, if it helps control the disease, and how the body processes it. Participants will …

This study is testing whether a new drug called HRS-8080 works better than treatments doctors normally choose for women with advanced breast cancer that has stopped responding to hormone therapy. It will involve 240 women whose cancer has spread or is locally advanced. The main g…

This is the first study in people testing a new drug called HRS-6208 for patients with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and understand the drug's side effects in about 206 participants. Researchers wil…

This study is testing several new combinations of investigational drugs for people with advanced breast cancer that cannot be surgically removed or has spread. The main goals are to find safe doses and see if these combinations can help control the cancer. It will enroll about 30…

This study is testing a new investigational drug called HRS-1301 to see if it can safely lower high cholesterol levels. It will involve 189 adults with high cholesterol, some of whom have heart disease. Participants will receive either the drug or a placebo for 12 weeks to compar…

This is the first study in people testing a new cancer drug called HRS-3802. It aims to find a safe dose and see how the body handles the drug in 100 adults with advanced solid tumors that have not responded to standard treatments. Researchers will monitor for side effects and ch…

This is the first study in people to test a new oral drug called HRS-7058. It aims to find a safe dose and see early signs of effectiveness in adults with advanced solid tumors that have a specific genetic change (KRAS G12C mutation). The study will enroll about 233 participants …

This study is checking the long-term safety of the experimental drug HRS-1893 in people with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. It will follow 300 patients who have already taken this medication in previous studies. Researchers will monitor …

This study is testing whether a new drug called HRS-7058, when combined with other cancer drugs, is safe and effective for treating advanced solid tumors. It will involve about 300 adults with cancers that cannot be surgically removed or have spread. The main goals are to find th…

This study is testing a new medication called HRS-2129 to help manage pain after orthopedic surgery. Researchers want to find out if the drug is safe and effective, and determine the best dosage for pain relief. The trial will involve 195 people who are scheduled for elective ort…

This study is testing a new investigational drug called HRS-2129 to see if it can safely and effectively reduce pain after abdominal surgery. It will involve 360 adults who have just had this type of operation. The goal is to see if this drug provides better pain relief over 48 h…

This study is testing a new oral medication called HRS-2129 to see if it can reduce pain and improve function in people with moderate to severe knee osteoarthritis. It will involve about 200 participants and compare different doses of the drug against a placebo and an existing pa…

This early-stage study aims to understand how a new drug for a heart muscle disease (cardiomyopathy) is absorbed by the body. It will test two different pill versions and see if taking the pill with food changes how it works. The study involves 38 healthy adults and will closely …

This early-stage study aims to understand how a new investigational drug for weight management, called HRS-7535, interacts with four common medications: acetaminophen (pain/fever), digoxin (heart), rosuvastatin (cholesterol), and omeprazole (heartburn). It will enroll 40 overweig…